Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Akebia Therapeutics, Inc. AKBA

Full chart Compare
Set alert

Price alert · AKBA

All alert types
0.43 USD -0.27 (-38.75%)

At closeNov 5, 2026, 5:06 PM EST

0.43 0.00 +1.06%

After hours · Nov 5, 5:06 PM ET

0.4238 Day range 0.5475
0.4238 52-week range 2.11
YTD
-73.57%
1 year
-79.93%

Financial health

Altman Z-Score

-6.24 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -77.4×
FY 2016: -2.9×FY 2017: -8.4×FY 2018: -3.8×FY 2019: -2.7×FY 2020: -1.1×FY 2021: -1.5×FY 2022: -1.0×FY 2023: -4.4×FY 2024: -5.8×FY 2025: -77.4×
FY 2016 5y median -4.4× FY 2025
P/S 1.8×
FY 2016: 256×FY 2017: 3.6×FY 2018: 3.1×FY 2019: 2.2×FY 2020: 1.3×FY 2021: 1.8×FY 2022: 0.4×FY 2023: 1.2×FY 2024: 2.5×FY 2025: 1.8×
FY 2016 5y median 1.8× FY 2025
P/B 12.7×
FY 2016: 5.8×FY 2017: 5.4×FY 2018: 1.0×FY 2019: 1.9×FY 2020: 1.6×FY 2021: 5.1×FY 2022: 20.2×FY 2023: -7.6×FY 2024: -8.1×FY 2025: 12.7×
FY 2016 5y median 5.1× FY 2025
P/FCF 6.1×
FY 2016: 7.1×FY 2017: -11.2×FY 2018: -6.5×FY 2019: -2.8×FY 2020: -3.5×FY 2021: -1.5×FY 2022: -1.4×FY 2023: -9.9×FY 2024: -9.8×FY 2025: 6.1×
FY 2016 5y median -1.5× FY 2025
EV/EBITDA 20.5×
FY 2016: -1.5×FY 2017: -7.6×FY 2018: -3.2×FY 2019: -2.9×FY 2020: -2.0×FY 2021: -2.2×FY 2022: 37.6×FY 2023: -35.5×FY 2024: -39.2×FY 2025: 20.5×
FY 2016 5y median -2.2× FY 2025
EV/Sales 1.9×
FY 2016: 134×FY 2017: 3.2×FY 2018: 2.7×FY 2019: 2.1×FY 2020: 1.0×FY 2021: 2.0×FY 2022: 0.4×FY 2023: 1.5×FY 2024: 3.4×FY 2025: 1.9×
FY 2016 5y median 1.9× FY 2025
FCF Yield 16.4%
FY 2016: 14.1%FY 2017: -8.9%FY 2018: -15.3%FY 2019: -35.3%FY 2020: -28.6%FY 2021: -67.5%FY 2022: -69.5%FY 2023: -10.1%FY 2024: -10.2%FY 2025: 16.4%
FY 2016 5y median -10.2% FY 2025

Profitability

Gross Margin 83.3%
FY 2016: -7443.0%FY 2017: 99.7%FY 2018: 96.3%FY 2019: 56.6%FY 2020: 78.3%FY 2021: 61.5%FY 2022: 92.3%FY 2023: 61.9%FY 2024: 60.6%FY 2025: 83.3%
FY 2016 5y median 61.9% FY 2025
Operating Margin 9.9%
FY 2016: -8889.9%FY 2017: -44.9%FY 2018: -85.8%FY 2019: -85.5%FY 2020: -128.2%FY 2021: -125.0%FY 2022: -27.6%FY 2023: -23.8%FY 2024: -31.5%FY 2025: 9.9%
FY 2016 5y median -27.6% FY 2025
Net Margin -2.3%
FY 2016: -8843.5%FY 2017: -43.2%FY 2018: -82.7%FY 2019: -83.5%FY 2020: -130.6%FY 2021: -133.3%FY 2022: -32.2%FY 2023: -26.7%FY 2024: -43.3%FY 2025: -2.3%
FY 2016 5y median -32.2% FY 2025
ROE -16.4%
FY 2016: -199.3%FY 2017: -64.5%FY 2018: -27.0%FY 2019: -70.8%FY 2020: -155.4%FY 2021: -381.1%FY 2022: -1801.6%FY 2023: 169.8%FY 2024: 141.1%FY 2025: -16.4%
FY 2016 5y median -16.4% FY 2025
ROIC 9.3%
FY 2016: -72.9%FY 2017: -35.0%FY 2018: -19.9%FY 2019: -49.2%FY 2020: -81.7%FY 2021: -71.4%FY 2022: -30.7%FY 2023: -27.9%FY 2024: -33.8%FY 2025: 9.3%
FY 2016 5y median -30.7% FY 2025
ROA -1.4%
FY 2016: -45.2%FY 2017: -21.1%FY 2018: -17.3%FY 2019: -36.3%FY 2020: -59.7%FY 2021: -53.3%FY 2022: -26.5%FY 2023: -21.5%FY 2024: -31.5%FY 2025: -1.4%
FY 2016 5y median -26.5% FY 2025

Growth (YoY)

Revenue 47.5%
FY 2016: 0.0%FY 2017: 11495.0%FY 2018: 16.7%FY 2019: 61.3%FY 2020: -12.0%FY 2021: -28.2%FY 2022: 38.2%FY 2023: -33.5%FY 2024: -17.7%FY 2025: 47.5%
FY 2016 FY 2025
Operating Income 146.6%
FY 2016: -121.8%FY 2017: 41.4%FY 2018: -122.9%FY 2019: -60.7%FY 2020: -32.0%FY 2021: 30.0%FY 2022: 69.5%FY 2023: 42.7%FY 2024: -9.1%FY 2025: 146.6%
FY 2016 FY 2025
EPS (diluted) 93.7%
FY 2016: -57.2%FY 2017: 50.8%FY 2018: 16.9%FY 2019: -60.5%FY 2020: -7.2%FY 2021: 41.5%FY 2022: 60.8%FY 2023: 51.7%FY 2024: -17.9%FY 2025: 93.7%
FY 2016 FY 2025
Free Cash Flow 267.1%
FY 2016: 204.6%FY 2017: -204.6%FY 2018: -71.5%FY 2019: -166.5%FY 2020: 58.1%FY 2021: -128.6%FY 2022: 71.0%FY 2023: 68.1%FY 2024: -74.0%FY 2025: 267.1%
FY 2016 FY 2025

Financial Health

Current Ratio 1.1×
FY 2016: 2.6×FY 2017: 2.5×FY 2018: 1.8×FY 2019: 1.5×FY 2020: 2.0×FY 2021: 1.0×FY 2022: 1.4×FY 2023: 1.2×FY 2024: 1.4×FY 2025: 1.1×
FY 2016 5y median 1.2× FY 2025
Quick Ratio 1.0×
FY 2016: 2.6×FY 2017: 2.5×FY 2018: 1.3×FY 2019: 0.9×FY 2020: 1.7×FY 2021: 0.9×FY 2022: 1.3×FY 2023: 1.0×FY 2024: 1.2×FY 2025: 1.0×
FY 2016 5y median 1.0× FY 2025
Debt / Equity 6.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.3×FY 2020: 0.5×FY 2021: 2.6×FY 2022: 19.1×FY 2023: -3.4×FY 2024: -3.8×FY 2025: 6.6×
FY 2016 5y median 2.6× FY 2025
Net Debt / EBITDA 1.4×
FY 2016: 1.4×FY 2017: 0.9×FY 2018: 0.5×FY 2019: 0.2×FY 2020: 0.7×FY 2021: -0.2×FY 2022: 3.0×FY 2023: -7.4×FY 2024: -10.0×FY 2025: 1.4×
FY 2016 5y median -0.2× FY 2025
Interest Coverage 1.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -204×FY 2020: -42.6×FY 2021: -13.3×FY 2022: -5.1×FY 2023: -7.7×FY 2024: -2.8×FY 2025: 1.0×
FY 2016 5y median -5.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31